MINDBODY Announces Schedule of Upcoming Investor Conferences
Nov 08, 2016 21:05 pm UTC| Business
SAN LUIS OBISPO, Calif., Nov. 08, 2016 -- MINDBODY, Inc. (NASDAQ:MB), the leading provider of cloud-based business management software for the wellness services industry, today announced that management will be...
Nov 08, 2016 21:05 pm UTC| Business
ST. LOUIS, Nov. 08, 2016 -- Amdocs (NASDAQ:DOX), the leading provider of customer experience solutions, today announced the availability of its Mobile Financial Services card management system, which supports service...
FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update
Nov 08, 2016 21:03 pm UTC| Business
– Completes Enrollment of Roxadustat Phase 3 Studies in China for Anemia in CKD – – Conference Call and Webcast to be Held Today at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time – SAN FRANCISCO,...
Sientra® Reports Third Quarter 2016 Financial Results
Nov 08, 2016 21:03 pm UTC| Business
Highlights On track to submit PMA supplement for new manufacturing by end of Q1 2017 with resupply commencing in Q4 2017Acquired Specialty Surgical Products, Inc. tissue expander portfolio to further penetrate $235 million...
Xenon Pharmaceuticals to Present at the Stifel 2016 Healthcare Conference
Nov 08, 2016 21:02 pm UTC| Business
BURNABY, British Columbia, Nov. 08, 2016 -- Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's President and Chief Executive Officer,...
SAExploration Announces New $35 Million Deep Water Ocean-Bottom Marine Project Award
Nov 08, 2016 21:02 pm UTC| Business
HOUSTON, Nov. 08, 2016 -- SAExploration Holdings, Inc. (NASDAQ:SAEX), or SAE, today announced a new project award for seismic data acquisition services valued at approximately $35 million. The award is for a 3D deep...
Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results
Nov 08, 2016 21:01 pm UTC| Business
Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017Apricus Granted Type B Meeting with FDA to Discuss the Vitaros® U.S. NDA Re-SubmissionConference Call / Webcast Today, Tuesday, November...